...
首页> 外文期刊>BMC Biotechnology >Engineering selection stringency on expression vector for the production of recombinant human alpha1-antitrypsin using Chinese Hamster ovary cells
【24h】

Engineering selection stringency on expression vector for the production of recombinant human alpha1-antitrypsin using Chinese Hamster ovary cells

机译:用中国仓鼠卵巢细胞生产重组人α1-抗胰蛋白酶的表达载体的工程选择严格性

获取原文

摘要

Background Expression vector engineering technology is one of the most convenient and timely method for cell line development to meet the rising demand of novel production cell line with high productivity. Destabilization of dihydrofolate reductase (dhfr) selection marker by addition of AU-rich elements and murine ornithine decarboxylase PEST region was previously shown to improve the specific productivities of recombinant human interferon gamma in CHO-DG44 cells. In this study, we evaluated novel combinations of engineered motifs for further selection marker attenuation to improve recombinant human alpha-1-antitrypsin (rhA1AT) production. Motifs tested include tandem PEST elements to promote protein degradation, internal ribosome entry site (IRES) mutations to impede translation initiation, and codon-deoptimized dhfr selection marker to reduce translation efficiency.
机译:背景表达载体工程技术是细胞系开发中最方便,最及时的方法之一,可以满足对高生产率的新型生产细胞系不断增长的需求。先前已显示,通过添加富含AU的元素和鼠鸟氨酸脱羧酶PEST区域使二氢叶酸还原酶(dhfr)选择标记不稳定,可以提高重组人干扰素γ在CHO-DG44细胞中的特异性生产力。在这项研究中,我们评估了工程化基序的新组合,以进一步减少标记的衰减,以改善重组人α-1-抗胰蛋白酶(rhA1AT)的产生。测试的基序包括串联PEST元素以促进蛋白质降解,内部核糖体进入位点(IRES)突变以阻止翻译起始,以及密码子去优化的dhfr选择标记以降低翻译效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号